Yolanda Jeréz Gilarranz

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Hospital General Universitario Gregorio Marañón(Current)

Hospital Universitario 12 De Octubre

Texas Oncology

Hospital Clínico San Carlos

Yolanda Jeréz Gilarranz is an author at Hospital General Universitario Gregorio Marañón specializing in oncology, her2-positive breast cancer, and breast oncology.

Publications per year

2023–2025

Publications

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

Nicholas C. Turner, Cristina Saura, Philippe Aftimos et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort

Rodrigo Sánchez-Bayona, Alfonso López de, Yolanda Jeréz Gilarranz et al. · Breast Cancer Research and Treatment · 2024 · 17 citations

Medicine, Endocrinology, Oncology +17

Abstract PD13-12: PD13-12 Imlunestrant, an oral selective estrogen receptor degrader, in combination with abemaciclib with or without an aromatase inhibitor, in estrogen receptor-positive advanced breast cancer: Results from the phase 1a/b EMBER study

Komal Jhaveri, Hwei-Chung Wang, Elgene Lim et al. · Cancer Research · 2023 · 11 citations

Medicine, Oncology, Pharmacology +17

Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study

Regina Peña-Enríquez, Begoña Bermejo, Marina Pollán et al. · npj Breast Cancer · 2025 · 10 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–4 of 4